North Carolina Administrative Code
Title 11 - INSURANCE
Chapter 23 - INDUSTRIAL COMMISSION
Subchapter M - RULES FOR THE UTILIZATION OF OPIOIDS, RELATED PRESCRIPTIONS, AND PAIN MANAGEMENT TREATMENT IN WORKERS' COMPENSATION CLAIMS
Section .0300 - UTILIZATION RULES FOR OPIOID ANTAGONISTS
Section 23M .0301 - CO-PRESCRIPTION OF OPIOID ANTAGONIST
Current through Register Vol. 39, No. 6, September 16, 2024
(a) A health care provider prescribing a targeted controlled substance shall consider co-prescribing an opioid antagonist to the following:
(b) If a health care provider prescribes an opioid antagonist pursuant to one or more of the conditions listed in Paragraph (a) of this Rule, the health care provider shall write the prescription to allow for product selection by the employer or carrier, including an intranasal formulation approved by the United States Food and Drug Administration.
Authority 97-25;
97-25.4; 97-80(a); S.L. 2017-203, s. 4;
Eff. May 1,
2018;
Recodified from
04 NCAC
10M .0301 Eff. June 1,
2018.